ABSTRACT OBJECTIVES: To explore the neutrophil-lymphocyte ratio (NLR) in patients with prehypertension (PHT). BACKGROUND: Infl ammation plays an important role in the development of cardiovascular diseases. A pathophysiological link also exists between infl ammation and PHT. NLR is a simple marker for the assessment of infl ammatory status. There is a lack of data regarding the association between NLR and pre-hypertensive state. METHODS: The present cross-sectional study included 33 newly diagnosed PHT patients and 35 normotensive control subjects. Prehypertension was defi ned as a systolic blood pressure (BP) of 120-139 mm Hg and/or a diastolic BP of 80-89 mm Hg. RESULTS: Patients were divided into tertiles based on NLR values: 1.17 (0.9-1.42) in tertile 1; 1.57 (1.43-1.78) in tertile 2; and 2.40 (1.82-4.5) in tertile 3. The frequency of PHT was signifi cantly higher for patients in the upper NLR tertile compared to the middle and lower NLR tertiles (21 (91.3 %), 7 (30.4 %), and 5 (22.7 %), respectively; p < 0.001). Systolic BP and diastolic BP were signifi cantly higher among patients in the upper NLR tertile than among those in the other NLR tertiles. CONCLUSION: An association exists between PHT and NLR. NLR measurement, as well as monocyte count, may be used to indicate increased risk of prehypertension (Tab. 2, Ref. 48). Text in PDF www.elis.sk.
Introduction
Prehypertension (PHT) has been defi ned as a systolic blood pressure (BP) of 120-139 mm Hg and/or a diastolic blood pressure of 80-89 mm Hg (1) . The PHT designation serves to identify individuals who are potentially at higher risk for developing hypertension (HT) compared to those with optimal BP (< 120/80 mm Hg) (2, 3) . In the past few years, several prospective and cross-sectional studies have reported an elevated risk of coronary vascular disease (e.g., coronary heart disease and myocardial infarction) in prehypertensive subjects (4) (5) (6) (7) (8) . Thus, it is important to understan the pathogenesis of PHT, as PHT may be the fi rst sign of cardiovascular disease (CVD) in some cases.
Several studies have shown that infl ammation appears to play an important role in the development of cardiovascular diseases (9, 10) . Elevated levels of systemic infl ammatory markers have been found to be associated with the incidence of cardiovascular diseases, such as coronary artery disease, HT, and atrial fi brillation (4, 5, 11) . White blood cell (WBC) count and its subtypes are related to enhanced cardiovascular risk factors (6, 12) . The neutrophil-lymphocyte ratio (NLR) has been evaluated as a new predictor for cardiovascular risk (6) .
Despite the importance of PHT on cardiovascular outcomes, insuffi cient data exists on the potential association between the NLR and PHT. The NLR has never been investigated in prehypertensive patients. Therefore, the aim of this study was to explore the NLR in patients with PHT.
Materials and methods
The present study has a cross-sectional design. Power analysis suggested that a sample size of 25 was needed with an alpha of 0.05 for a power of 0.80. Thirty-three newly diagnosed PHT patients who had been admitted to our outpatient clinic for general check-up were selected. Thirty-fi ve age-and sex-matched healthy volunteers were recruited for the control group. The investigation complied with the principles outlined in the Declaration of Helsinki. The study was approved by the local ethics committee, and all participants provided written informed consent before participating.
Prehypertension was defi ned as a systolic BP of 120-139 mmHg and/or a diastolic BP of 80-89 mmHg. BP measurements were performed on the right arm using a sphygmomanometer (Erka, Erlangen, Germany) after 10 minutes of rest in a seated position. The average of two blood pressure measurements obtained at least three minutes apart was recorded for each patient. The nurse specialist determined the mean BP. Ambulatory BP monitoring was not performed. Patients who had PHT but were otherwise healthy were included. Exclusion criteria included drug use, morbid obesity (body mass index ≥ 35 kg/m2), diabetes mellitus, metabolic syndrome, dyslipidemia, renal dysfunction (serum creatinine > 1.5 mg/dl, blood urea nitrogen > 30 mg/dl), heart failure, valvular diseases, asthma, chronic obstructive pulmonary disease, peripheral and cerebral vascular disease, hematological disorders, acute or chronic infection, cancer, infl ammatory disease, and hepatic dysfunction.
Biochemical measurements
Venous blood samples were drawn at initial presentation from the antecubital vein. Total and differential leukocyte counts and routine biochemical tests were performed.
Statistical analysis
Data were analyzed using the SPSS software version 15.0 for Windows (SPSS Inc., Chicago, Illinois). The KolmogorovSmirnov test was used to verify the normality of the distribution for continuous variables. Continuous variables were defi ned as mean and standard deviation; categorical variables were given as percentages. The independent sample t test or the Mann-Whitney U test was used for continuous variables, and the chi-square test was used for categorical variables. One-way ANOVA or the KruskalWallis test was performed for the comparison of multiple groups. Pearson analysis was used to evaluate correlations. Statistical signifi cance was defi ned as p < 0.05.
Results
Patients were divided into tertiles based on NLR values: 1.17 (0.90-1.42) in tertile 1; 1.57 (1.43-1.78) in tertile 2; and 2.40 (1.82-4.50) in tertile 3. Baseline demographic, hemodynamic, and biochemical and hematological characteristics of the study population tertiles are shown in Table 1 . There were no statistically signifi cant differences between the groups with respect to age, gender, body mass index, smoking, or hemoglobin.
The frequency of the prehypertensive state was signifi cantly higher among patients in the upper NLR tertile compared to the middle and lower tertiles (21 (91.3 %), 7 (30.4 %), and 5 (22.7 %), respectively; p < 0.001). There was no signifi cant difference between the middle and lower NLR tertile groups in terms of pre- Table 2 demonstrates the characteristics of the prehypertensive patients compared to the normotensive controls. Biochemical and hematological parameters were comparable between groups except neutrophil and lymphocyte counts. In the PHT group, neutrophil count was signifi cantly higher (4.4 ± 1.2 versus 3.8 ± 0.9; p = 0.03) and lymphocyte count was signifi cantly lower (2.2 ± 0.5 versus 2.7 ± 0.6; p = 0.002) than in normotensive subjects. As a result, patients with PHT had signifi cantly higher NLR values compared to the control group (2.07 ± 0.74 versus 1.41 ± 0.29; p < 0.001). Pearson analysis revealed a positive correlation between NLR and both systolic BP (r = 0.424; p < 0.001) and diastolic BP (r = 0.492; p < 0.001).
Discussion
In the present study, a higher NLR, a reliable marker of infl ammation, was found to be statistically associated with the presence of PHT. In addition, the NLR was signifi cantly correlated with both systolic and diastolic BP.
Many prospective cohort studies have demonstrated an association between BP levels and risk of CVD, stroke, and premature death (1, 13) . Increased CVD risk begins at systolic BP levels as low as 115 mm Hg (14) . The longitudinal data from the Framingham Heart Study have clearly shown that individuals with BPs of 120-139/80-89 mm Hg are at increased risk of developing full-blown HT and CVD later in life than individuals with BPs less than 120/80 mm Hg (2) . Studies in the United States and other populations have identifi ed an association between increased WBC count and BP (15) (16) (17) . The relationship between leukocytes and increased cardiovascular risk is well known. Infl ammation is involved in the pathogenesis of several CVD (18, 19). Elevated WBC count is associated with deaths from cardiovascular causes, with the extent of coronary heart disease as well as with cardiovascular mortality, combined cardiovascular mortality and morbidity, myocardial infarction, congestive heart failure and stroke (20-25).
Horne et al. examined the predictive ability of total WBC count and its subtypes for risk of death and myocardial infarction. They found that high neutrophil and monocyte counts, low lymphocyte count, and high NLR are independently related to increased number of cardiovascular events (27). Leukocyte subtype counts and NLR are also indicators of systemic infl ammation (27 Several recent studies have supported the hypothesis that infl ammatory cells contribute to HT. The TNF-α antagonist etanercept reduces the HT caused by fructose feeding, prevents vascular dysfunction, and blunts the HT caused by angiotensin II. Etanercept was also determined to lower BP in an autoimmune model of chronic infl ammation (33-35). In some cases, TNF-α antagonism prevents end-organ damage without lowering BP. For example, etanercept prevents renal injury in salt-dependent HT without lowering BP and reduces albuminuria and renal infl ammation in transgenic hypertensive rats (36, 37). More recently, the novel, proinfl ammatory cytokine IL-17 was found to contribute to HT. IL-17 has been implicated in a variety of diseases, including rheumatoid arthritis, infl ammatory bowel disease, psoriasis, and airway infl ammation (38). IL-17 is also produced by CD8 cells, neutrophils, and natural killer T cells (39-41). IL-17 promotes chemotaxis of other infl ammatory cells, in part by stimulating the release of chemokines (42). The vascular accumulation of leukocytes (including T cells) caused by angiotensin II was determined to be markedly reduced in mice (42). Thus, IL-17 may contribute to the vascular pathophysiology of HT not only via its direct effects, but also by recruiting other infl ammatory cells to the perivascular tissue.
Stimuli, such as angiotensin II, sodium, and others, cause a modest elevation in BP to values of approximately 135 to 140 mm Hg (43). These initial elevations in pressure are largely due to central actions, but also require the direct effects of angiotensin II on peripheral sites. This fi rst phase of modest pressure elevation, often referred to as prehypertension, causes an infl ammatory response, likely by generating neoantigens that activate T cells. The infl ammatory response leads to entry of effector-like T cells into the perivascular fat and the kidneys. Macrophage infi ltration is also promoted, in part because of signals from T cells (43).
In the NHANES III and REGARDS studies, individuals with PHT were found to have a higher level of C-reactive protein (44, 45). In the ATTICA study, a range of infl ammatory markers, such as tumor necrosis factor-α, amyloid A, endothelin 1, homocysteine, advanced glycation products, and elevated WBC counts, were found to be signifi cantly higher in prehypertensives compared to normotensives (46). Recently, Tian et al. investigated the association between specifi c circulating leukocyte types and BP and found that BP is related to both neutrophils and lymphocytes (47). Kawada et al. showed an independent relationship between neutrophil count and HT (48). Our fi ndings were compatible with these study results.
To our knowledge, this is the fi rst study to show an association between PHT and NLR. Further studies are needed to clarify the role of NLR in PHT patients, especially in relation to biochemical and clinical parameters, before we conclude that NLR may be used as a follow-up marker. This study was limited by a relatively small sample size.
Conclusion
An association exists between PHT and NLR. NLR measurement, as well as monocyte count, may be used to indicate increased risk of prehypertension. 
